Your browser doesn't support javascript.
loading
Efficacy and safety of guselkumab compared with placebo and adalimumab in Korean patients with moderate-to-severe psoriasis: post-hoc analysis from the phase III, double-blind, placebo- and active-comparator-controlled VOYAGE 1/2 trials.
Youn, Sang Woong; Yu, Dae Young; Kim, Tae Yoon; Kim, Byung Soo; Lee, Seung Chul; Lee, Jeung Hoon; Choe, Yong-Beom; Lee, Joo-Heung; Choi, Jee-Ho; Roh, Joo Young; Jo, Seong Jin; Lee, Eun-So; Shin, Min Kyung; Lee, Min-Geol; Jiang, Jingzhi; Lee, YoungJa.
Afiliación
  • Youn SW; Department of Dermatology, Seoul National University Bundang Hospital and Seoul National University College of Medicine, Seongnam, Korea.
  • Yu DY; Medical Affairs, Janssen Korea Ltd., Seoul, Korea.
  • Kim TY; Department of Public Health, Korea University College of Medicine, Seoul, Korea.
  • Kim BS; Department of Dermatology, Catholic University of Korea Seoul St. Mary's Hospital, Seoul, Korea.
  • Lee SC; Department of Dermatology, Pusan National University School of Medicine, Busan, Korea.
  • Lee JH; Department of Dermatology, Chonnam National University Hospital, Gwangju, Korea.
  • Choe YB; Department of Dermatology, Chungnam National University Hospital, Daejeon, Korea.
  • Lee JH; Department of Dermatology, Konkuk University School of Medicine, Seoul, Korea.
  • Choi JH; Department of Dermatology, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Korea.
  • Roh JY; Department of Dermatology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
  • Jo SJ; Department of Dermatology, Gachon University College of Medicine, Gil Medical Center, Incheon, Korea.
  • Lee ES; Department of Dermatology, Seoul National University College of Medicine, Seoul, Korea.
  • Shin MK; Department of Dermatology, Ajou University Hospital, Suwon, Korea.
  • Lee MG; Department of Dermatology, Kyunghee University Medical Center, Seoul, Korea.
  • Jiang J; Department of Dermatology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
  • Lee Y; Janssen Research & Development LLC, Spring House, PA, USA.
J Dermatolog Treat ; 33(1): 535-541, 2022 Feb.
Article en En | MEDLINE | ID: mdl-32419536

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Psoriasis Límite: Humans País/Región como asunto: Asia Idioma: En Revista: J Dermatolog Treat Asunto de la revista: DERMATOLOGIA Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Psoriasis Límite: Humans País/Región como asunto: Asia Idioma: En Revista: J Dermatolog Treat Asunto de la revista: DERMATOLOGIA Año: 2022 Tipo del documento: Article